Cargando…
Unsupervised [(18)F]Flortaucipir cutoffs for tau positivity and staging in Alzheimer’s disease
PURPOSE: Several [(18)F]Flortaucipir cutoffs have been proposed for tau PET positivity (T(+)) in Alzheimer’s disease (AD), but none were data-driven. The aim of this study was to establish and validate unsupervised T(+) cutoffs by applying Gaussian mixture models (GMM). METHODS: Amyloid negative (A(...
Autores principales: | Quattrini, Giulia, Ferrari, Clarissa, Pievani, Michela, Geviti, Andrea, Ribaldi, Federica, Scheffler, Max, Frisoni, Giovanni B, Garibotto, Valentina, Marizzoni, Moira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542510/ https://www.ncbi.nlm.nih.gov/pubmed/37272955 http://dx.doi.org/10.1007/s00259-023-06280-7 |
Ejemplares similares
-
International consensus on the use of tau PET imaging agent (18)F-flortaucipir in Alzheimer’s disease
por: Tian, Mei, et al.
Publicado: (2022) -
Prognostic value of imaging-based ATN profiles in a memory clinic cohort
por: Peretti, Débora E., et al.
Publicado: (2023) -
Brain connectivity and metacognition in persons with subjective cognitive decline (COSCODE): rationale and study design
por: Ribaldi, Federica, et al.
Publicado: (2021) -
(18)F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes
por: Tsai, Richard M., et al.
Publicado: (2019) -
Evaluation of a visual interpretation method for tau‐PET with (18)F‐flortaucipir
por: Sonni, Ida, et al.
Publicado: (2020)